首页> 美国卫生研究院文献>Case Reports in Nephrology and Dialysis >Faecal Microbiota Transplantation Eradicated Extended-Spectrum Beta-Lactamase-Producing Klebsiella pneumoniae from a Renal Transplant Recipient with Recurrent Urinary Tract Infections
【2h】

Faecal Microbiota Transplantation Eradicated Extended-Spectrum Beta-Lactamase-Producing Klebsiella pneumoniae from a Renal Transplant Recipient with Recurrent Urinary Tract Infections

机译:从肾移植受者复发性尿路感染的粪便菌群移植根除扩大范围的β-内酰胺酶生产肺炎克雷伯菌。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Renal transplant recipients (RTRs) are highly susceptible to infections, and antimicrobial resistance is an increasing problem with limited treatment options. Faecal microbiota transplantation (FMT) is effective for recurrent Clostridium difficile infection and may be used for patients with intestinal carriage of multidrug-resistant (MDR) microorganisms. We present a RTR who suffered from recurrent urinary tract infections (UTIs) caused by extended-spectrum beta-lactamase-producing (ESBL+) Klebsiella pneumoniae. Blood and urinary isolates revealed the same antibiotic susceptibility pattern, and whole-genome sequencing confirmed identical isolates in blood and urine. Despite several treatments with meropenem, the patient experienced recurrent infections that caused hospitalisation. ESBL+ K. pneumoniae was isolated in faeces. In an attempt to decolonise the gut, FMT was performed. A few days after nasojejunal infusion of donor faeces, the patient experienced a single relapse of UTI. During the subsequent 12 months, no further episodes of UTI occurred. Absence of ESBL+ K. pneumoniae in urine and faeces was demonstrated during follow-up. We conclude that FMT may be an effective treatment in RTRs with recurrent UTIs caused by intestinal colonisation with MDR organisms.
机译:肾移植受者(RTR)极易感染,并且在有限的治疗选择中,抗菌素耐药性问题日益严重。粪便微生物菌群移植(FMT)对于复发性艰难梭菌感染有效,可用于具有多药耐药性(MDR)肠道运输的患者。我们介绍了一个RTR,患有由广谱β-内酰胺酶生产(ESBL +)肺炎克雷伯菌引起的尿路反复感染(UTIs)。血液和尿液分离株显示出相同的抗生素敏感性模式,全基因组测序证实血液和尿液中分离株相同。尽管使用美洛培南有数种治疗方法,但患者仍经历反复感染而导致住院。在粪便中分离出ESBL +肺炎克雷伯菌。为了使肠道非殖民化,进行了FMT。鼻空肠输注供者粪便后几天,患者经历了单次UTI复发。在随后的12个月中,没有再发生UTI发作。在随访期间,尿液和粪便中没有ESBL +肺炎克雷伯菌。我们得出的结论是,FMT可能是由MDR生物体在肠道定植引起的UTI复发的RTR中的有效治疗方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号